Results 81 to 90 of about 37,214 (250)

Changes of Periodontal Conditions of First and Second Molars With Furcation Involvement Grade II or III ‐ a Retrospective Analysis of 14 to 17 Year Follow‐up

International Journal of Dental Hygiene, EarlyView.
ABSTRACT Objective This retrospective analysis aimed to evaluate the clinical changes and survival rate of first and second molars with furcation involvement (F‐Inv) grades II and III after completion of non‐surgical active periodontal therapy (APT) and subsequent supportive periodontal therapy (SPT), with a minimum follow‐up period of 14 years ...
Ayisha Gangadin, Cees Valkenburg, Fridus (G. A.) van der Weijden   +2 more
wiley   +1 more source

Comprehensive Approach to the Treatment and Prevention of Bisphosphonate-Induced Osteonecrosis of the Jaw

Juvenis Scientia
Osteonecrosis of the jaws (ONJ) is a severe complication associated with the administration of bisphosphonates, drugs used for the treatment of osteoporosis and metastatic bone disease.
Pilipov, I.A., Galstian, S.G., Timofeev, E.V.   +2 more
doaj   +1 more source

Multiple External Invasive Root Resorption and Calcification in Systemic Sclerosis—Case Report

International Endodontic Journal, EarlyView.
ABSTRACT Aim There are few reports in the literature of multiple external invasive root resorption (EIRR) lesions in patients with systemic sclerosis (SSc), and an association between root resorption and SSc is not well established. We report the only case that comprehensively illustrates—with the combination of histopathology, cone beam computed ...
Jee‐Yun Leung, Geoffrey Heithersay, Richard Logan, Sharon Liberali   +3 more
wiley   +1 more source

Ethylenediaminetetraacetic Acid and Other Dentine Bioactive Molecule‐Releasing Agents for Regenerative Endodontic Procedures: A Systematic Review

International Endodontic Journal, EarlyView.
ABSTRACT Background The bioactive molecules released from dentine are key to stem‐cell recruitment, proliferation and differentiation in regenerative endodontics. However, there is limited and conflicting information regarding current and potential agents for releasing dentine bioactive molecules for regenerative endodontic procedures.
Arwa Al‐Maswary, Xiaoxuan Deng, Haizal M. Hussaini, Lara T. Friedlander, Paul R. Cooper   +4 more
wiley   +1 more source

Bisphosphonates: from preclinical evidence to survival data in the oncologic setting

Oncology Reviews, 2011
Bisphosphonate therapy has become a standard of therapy for patients with malignant bone disease. In vivo pre-clinical data suggest that bisphosphonates may exert an antitumor effect and preliminary clinical data show promising activity on metastatic ...
Daniele Santini, Maria Elisabetta Fratto, Bruno Vincenzi, Silvia Angeletti, Giordano Dicuonzo, Gaia Schiavon, Giuseppe Tonini   +6 more
doaj   +2 more sources

Influence on persistence and adherence with oral bisphosphonates on fracture rates in osteoporosis

Patient Preference and Adherence, 2008
Ariane Höer1, Cornelia Seidlitz1, Holger Gothe1, Guido Schiffhorst1, Melvin Olson2, Peyman Hadji3, Bertram Häussler11IGES Institut, Friedrichstrasse 180, D-10117 Berlin, Germany; 2Novartis Pharma AG; 3Department of Gynaecology ...
Ariane Höer, Cornelia Seidlitz, Holger Gothe, Guido Schiffhorst, Melvin Olson, et al   +5 more
doaj  

Denosumab discontinuation and fracture risk: getting the balance right

Internal Medicine Journal, EarlyView.
Abstract Denosumab is a highly effective therapy for osteoporosis. Since its approval by the Therapeutic Goods Administration (TGA) in 2010, use of denosumab has surged across Australia, delivering substantial fracture‐prevention benefits to tens of thousands of patients. However, stopping denosumab may lead to acute loss of bone with an increased risk
Albert S. Kim, Christian M. Girgis
wiley   +1 more source

Hypophosphataemia following iron infusion: a narrative review of an increasingly recognised complication

Internal Medicine Journal, EarlyView.
Abstract Parenteral iron is widely prescribed by medical practitioners, with more than 600 000 outpatient prescriptions dispensed in 2025 through the Australian Pharmaceutical Benefits Scheme. While intravenous iron has transformed the management of iron deficiency, hypophosphataemia is now recognised as a common complication, with incidences reported ...
Brenda Ta, Stephanie Baddock, Jane Ludington, Angela Sheu   +3 more
wiley   +1 more source

Chronic pruritus treated with alendronate in bilateral striopallidodentate calcinosis associated with an SLC20A2 gene mutation

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Adrien Boyard, Florian Stéphan, Boris Chaumette, Mathilde Moreau, Laure Bleton, Nicolas Hornez, Steeve Genestet, Jérémy Betrand, Amélie Bourhis, Morgane Le Bon‐Jégo, Thierry Bienvenu, Camille Verebi, Laurent Misery   +12 more
wiley   +1 more source

Surgical Therapy for Peri‐Implantitis Using Deproteinised Bovine Bone Mineral With 10% Collagen, Enamel Matrix Derivative and Doxycycline: A Prospective Cohort 10‐Year Implant Study

Journal of Clinical Periodontology, EarlyView.
ABSTRACT Aim To assess 10‐year implant survival following surgical management of peri‐implantitis using deproteinised bovine bone mineral with 10% collagen (DBBMC), enamel matrix derivative (EMD) and doxycycline powder. Materials and Methods The original population comprised 30 non‐smoking, periodontally stable patients (mean age = 44.9 ± 11 years; 64%
Faustino Mercado, Saso Ivanovski
wiley   +1 more source